Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.250
-0.070 (-5.30%)
Dec 5, 2025, 4:00 PM EST - Market closed
Mustang Bio Employees
Mustang Bio had 6 employees as of December 31, 2024. The number of employees decreased by 74 or -92.50% compared to the previous year.
Employees
6
Change (1Y)
-74
Growth (1Y)
-92.50%
Revenue / Employee
n/a
Profits / Employee
-$389,167
Market Cap
9.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MBIO News
- 5 months ago - Dow Dips 1%; Mustang Bio Shares Spike Higher - Benzinga
- 5 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - GlobeNewsWire
- 9 months ago - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire
- 10 months ago - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewsWire
- 10 months ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 10 months ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 10 months ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 11 months ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire